HIV and Hepatitis.com Coverage of the
13th Annual Conference on Retroviruses and Opportunistic Infections
February 5 - 8, 2006, Denver, CO

Antiretroviral Treatment Strategies


Predictors for Changes in CD4 Cell Count 7 Years after Starting HAART

Metabolic and Morphologic Changes with PI-sparing Therapies

Does Earlier HAART Lead to Improved Clinical Status and Less Drug-related Toxicities?

Pilot Trial of Regimen Simplification to Atazanavir/Ritonavir Alone as Maintenance Antiretroviral Therapy